Glenmark Pharmaceuticals Inc., USA recalls Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx on
Recalled September 29, 2021 · FDA recall D-0820-2021 · Glenmark Pharmaceuticals Inc., USA
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
28658 cartons
Sold at
Nationwide.
Description
Lack of Assurance of Sterility
Product
Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →